FDA Panel Endorses Gene Therapy for Childhood Blindness
For the inherited retinal disease (IRD) community, regulatory milestones represent important steps forward in the journey toward accessible treatments. According to NPR reporting, an advisory panel to the U.S. Food and Drug Administration (FDA) has endorsed an experimental gene therapy designed to treat a form of inherited childhood blindness.